DTX1 and colitis: In contrast, the co-administration of Dtx1−/− tTregs only weakly reduced the colitis-associated pathogenesis (Fig. 2g–i), suggesting that the absence of DTX1 greatly diminished the suppressive activities of tTregs in vivo.